GLP-1 drugs like Ozempic and Wegovy are often portrayed as sudden breakthroughs, but their roots extend back more than a ...
A live webcast of the presentation will be accessible on the Events page in the Investors section of the Company’s website at palisadebio.com. A replay will be available following the live event and ...
In an interview with Targeted Oncology, Sarbajit Mukherjee, MD, gastrointestinal (GI) medical oncologist at Baptist Health ...
Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medicine ...
A team of researchers at VCU Massey Comprehensive Cancer Center discovered an innovative way to use a drug already approved ...
Researchers at University of Tsukuba have discovered that an immunosuppressive drug affects microglia, the resident immune ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of liver disease worldwide, affecting one in three people.1,2 The inflammatory form of MASLD, namely ...
As the management landscape of primary biliary cholangitis (PBC) changes, new second-line options offer effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results